{
    "organizations": [],
    "uuid": "72727650d05b0eccb8b51b70509afe8ee5229721",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dual-listed-therapix-to-voluntaril/brief-dual-listed-therapix-to-voluntarily-delist-from-tel-aviv-stock-exchange-idUSFWN1SG17C",
    "ord_in_thread": 0,
    "title": "BRIEF-Dual-Listed Therapix To Voluntarily Delist From Tel Aviv Stock Exchange",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Therapix Biosciences Ltd:\n* DUAL-LISTED THERAPIX TO VOLUNTARILY DELIST FROM TEL AVIV STOCK EXCHANGE\n* THERAPIX BIOSCIENCES LTD - DELISTING OF THERAPIXâ€™S ORDINARY SHARES FROM TRADING ON TASE EXPECTED TO BECOME EFFECTIVE THREE MONTHS FROM DATE OF REQUEST Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-09T20:42:00.000+03:00",
    "crawled": "2018-05-10T17:15:00.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "therapix",
        "bioscience",
        "ltd",
        "therapix",
        "voluntarily",
        "delist",
        "tel",
        "aviv",
        "stock",
        "exchange",
        "therapix",
        "bioscience",
        "ltd",
        "delisting",
        "therapix",
        "ordinary",
        "share",
        "trading",
        "tase",
        "expected",
        "become",
        "effective",
        "three",
        "month",
        "date",
        "request",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}